Renovo Grp Share Price (RNVO)

strange... cf asm & countless others..

ever have anything that worked. Even the placebo beat the treatment on this trial. Useless dosnt begin to describe this bunch of chancers.

20th September 2011 Notification of Interest and Director's Dealings Renovo Group plc has received notification that on 16 September 2011, Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), acquired 450,000 ordinary shares in the Company at a price of 14.17 pence per share. Kestrel Partners LLP, which Max Royde (Non-executive Director of the Company) is a partner of and holds a beneficial interest in, is the investment manager to Kestrel Opportunities. Mr Royde is also a shareholder in Kestrel Opportunities. Kestrel Opportunities holds 10,221,942 ordinary shares in the Company, which represents approximately 5.37 per cent of the Company's issued share capital.

Junior bio-tech firm Renovo Group (LON:RNVO) got the go-ahead from investors to proceed with a share buy-back programme. Following today’s AGM, in which all resolutions passed a shareholder vote, Renovo can now carry out its plans to step down from the LSE main market onto AIM and concurrently it will buy-back up to 25 per cent of the company’s share capital through a series of ‘on-market’ transactions. In February ReNovo shares fell around 75 per cent after it revealed that its lead drug, the scar treatment Juvista, failed to meet its goals in a major clinical trial. In the wake of the trial Renovo was left with a cash pile and intellectual property (IP) relating to two earlier stage drugs, Prevascar and Adaprev. The group has since streamlined its board of directors and it has scaled back its operations. It has closed down its labs and in the future the rest of the drug portfolio will be developed via contractors.

Although I feel that there is a profitable future in Renovo, I've sold up. I had them in my ISA, but as they plan to delist from the main market and relist on AIM, they will not qualify for inclusion in an ISA. Switched funds into POL . . . . . . . . . . good luck to all of you still holding.

Group Plc TIDM RNVO Headline Notification of Interest and Director's Dealings Released 07:00 22-Aug-2011 Number 7423M07 RNS Number : 7423M Renovo Group Plc 22 August 2011  RENOVO GROUP PLC Notification of Interest and Director's Dealings Renovo Group plc has received notification that on 19 August 2011, Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), acquired 350,000 ordinary shares in the Company at a price of 14.1 pence per share. Kestrel Partners LLP, which Max Royde (Non-executive Director of the Company) is a partner of and holds a beneficial interest in, is the investment manager to Kestrel Opportunities. Mr Royde is also a shareholder in Kestrel Opportunities. Kestrel Opportunities holds 9,771,942 ordinary shares in the Company, which represents approximately 5.1 per cent of the Company's issued share capital.